for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Avanos Medical Inc

AVNS.N

Latest Trade

31.03USD

Change

-1.32(-4.08%)

Volume

121,715

Today's Range

30.83

 - 

32.13

52 Week Range

30.83

 - 

53.45

As of on the New York Stock Exchange ∙ Minimum 15 minute delay

Latest Developments

Avanos Medical Appoints Michael Greiner As Chief Financial Officer

Dec 30 (Reuters) - Avanos Medical Inc <AVNS.N>::AVANOS MEDICAL APPOINTS MICHAEL C. GREINER AS CHIEF FINANCIAL OFFICER.AVANOS MEDICAL - GREINER, MOST RECENTLY SERVED AS CFO FOR ANGIODYNAMICS.

Avanos Medical, Inc. Announces Third Quarter 2019 Results, Completes Acquisition Of Endoclear Llc

Nov 5 (Reuters) - Avanos Medical Inc <AVNS.N>::AVANOS MEDICAL, INC. ANNOUNCES THIRD QUARTER 2019 RESULTS, COMPLETES ACQUISITION OF ENDOCLEAR LLC.Q3 ADJUSTED EARNINGS PER SHARE $0.30 FROM CONTINUING OPERATIONS.Q3 LOSS PER SHARE $0.24.Q3 SALES $171 MILLION VERSUS REFINITIV IBES ESTIMATE OF $179.8 MILLION.Q3 EARNINGS PER SHARE ESTIMATE $0.31 -- REFINITIV IBES DATA.REVISED ITS FULL-YEAR 2019 OUTLOOK FOR NET SALES GROWTH, IN CONSTANT CURRENCY, FROM 8 TO 10 PERCENT TO 5 TO 7 PERCENT.REVISED ITS FULL-YEAR 2019 OUTLOOK FOR ADJUSTED DILUTED EARNINGS PER SHARE FROM $1.15 TO $1.25 TO $1.00 TO $1.10.FY2019 EARNINGS PER SHARE VIEW $1.19, REVENUE VIEW $708.5 MILLION -- REFINITIV IBES DATA.

Avanos Medical, Inc. Announces Second Quarter 2019 Results

Aug 6 (Reuters) - Avanos Medical Inc <AVNS.N>::AVANOS MEDICAL, INC. ANNOUNCES SECOND QUARTER 2019 RESULTS, COMPLETES ACQUISITION OF NEOMED, INC., ANNOUNCES AGREEMENT TO ACQUIRE SUBSTANTIALLY ALL THE ASSETS OF SUMMIT MEDICAL PRODUCTS, INC., ANNOUNCES PARTNERSHIP AGREEMENT WITH BIOQ PHARMA.Q2 ADJUSTED EARNINGS PER SHARE $0.28 FROM CONTINUING OPERATIONS.Q2 LOSS PER SHARE $0.17.Q2 SALES $172 MILLION VERSUS REFINITIV IBES ESTIMATE OF $171.8 MILLION.Q2 EARNINGS PER SHARE ESTIMATE $0.25 -- REFINITIV IBES DATA.AVANOS MEDICAL - NOW EXPECTS FY NET SALES GROWTH OF 8 TO 10 PERCENT AND ADJUSTED DILUTED EARNINGS PER SHARE AT LOW-END OF ITS RANGE OF $1.15 TO $1.25..TO ACQUIRE SUBSTANTIALLY ALL ASSETS OF SUMMIT MEDICAL PRODUCTS INC. FOR APPROXIMATELY $18 MILLION.FY2019 EARNINGS PER SHARE VIEW $1.23, REVENUE VIEW $694.5 MILLION -- REFINITIV IBES DATA.

Avanos Medical Says Final Phase Of Multi-Year, Multi-Phase Restructuring Plan Approved - SEC Filing

June 18 (Reuters) - Avanos Medical Inc <AVNS.N>::AVANOS MEDICAL INC - ON JUNE 18, 2019, THIRD AND FINAL PHASE OF MULTI-YEAR, MULTI-PHASE RESTRUCTURING PLAN WAS APPROVED - SEC FILING.

Avanos Medical Inc Announces Tender Offer For Senior Notes

May 9 (Reuters) - Avanos Medical Inc <AVNS.N>::AVANOS MEDICAL, INC. ANNOUNCES TENDER OFFER FOR SENIOR NOTES.AVANOS MEDICAL - TO PURCHASE UP TO $129.8 MILLION IN AGGREGATE PURCHASE PRICE OF ITS OUTSTANDING 6.250 PERCENT SENIOR UNSECURED NOTES DUE OCTOBER 15, 2022.

Avanos Medical Posts Q1 Adjusted Earnings Per Share $0.15 From Continuing Operations

May 7 (Reuters) - Avanos Medical Inc <AVNS.N>::AVANOS MEDICAL, INC. ANNOUNCES FIRST QUARTER 2019 RESULTS.Q1 ADJUSTED EARNINGS PER SHARE $0.15 FROM CONTINUING OPERATIONS.Q1 LOSS PER SHARE $0.43.Q1 SALES ROSE 5 PERCENT TO $164 MILLION.REAFFIRMS FY 2019 ADJUSTED EARNINGS PER SHARE VIEW $1.15 TO $1.35.TOTAL DEBT AT END OF Q1 TOTALED $248 MILLION.MAINTAINS ITS FULL-YEAR 2019 ADJUSTED DILUTED EARNINGS PER SHARE OUTLOOK OF $1.15 TO $1.35.

Avanos Medical Appoints Warren Machan As Interim CFO

May 1 (Reuters) - Avanos Medical Inc <AVNS.N>::AVANOS MEDICAL INC - ON APRIL 25, 2019, APPOINTED WARREN J. MACHAN, AGE 53, TO SERVE AS INTERIM CFO, EFFECTIVE MAY 8, 2019 - SEC FILING.AVANOS MEDICAL INC - MACHAN WILL, ON AN INTERIM BASIS, SUCCEED STEVEN VOSKUIL, WHO, AS PREVIOUSLY DISCLOSED, NOTIFIED COMPANY OF HIS RESIGNATION.

Avanos Medical Inc Says CFO Steven Voskuil To Resign

April 18 (Reuters) - Avanos Medical Inc <AVNS.N>::AVANOS MEDICAL INC - ON APRIL 15, 2019, STEVEN VOSKUIL, CHIEF FINANCIAL OFFICER, NOTIFIED COMPANY THAT HE WAS RESIGNING EFFECTIVE AS OF MAY 8, 2019.AVANOS MEDICAL INC - COMPANY HAS COMMENCED A SEARCH FOR A NEW CHIEF FINANCIAL OFFICER TO SUCCEED VOSKUIL.AVANOS MEDICAL - VOSKUIL IS RESIGNING TO BECOME SENIOR VICE PRESIDENT AND CFO OF THE HERSHEY COMPANY.

Avanos Medical Reports Q4 Adjusted Earnings Per Share Of $0.30

Feb 26 (Reuters) - Avanos Medical Inc <AVNS.N>::AVANOS MEDICAL, INC. ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2018 RESULTS, PROVIDES 2019 OUTLOOK.Q4 LOSS PER SHARE $0.05.Q4 SALES ROSE 2 PERCENT TO $170 MILLION.EXPECTS 2019 NET SALES INCLUDING GAME READY, TO INCREASE 6 TO 8 PERCENT, ON A CONSTANT CURRENCY BASIS.AVANOS MEDICAL - SEES 2019 ADJUSTED EARNINGS PER SHARE OF $1.15 TO $1.35.Q4 ADJUSTED EARNINGS PER SHARE $0.30.

Avanos Medical Reports Q3 Adjusted Earnings Per Share $0.37

Nov 6 (Reuters) - Avanos Medical Inc <AVNS.N>::AVANOS MEDICAL, INC. ANNOUNCES THIRD QUARTER 2018 RESULTS, AFFIRMS FULL-YEAR ADJUSTED DILUTED EARNINGS PER SHARE GUIDANCE.Q3 ADJUSTED EARNINGS PER SHARE $0.37.Q3 EARNINGS PER SHARE $0.09.Q3 SALES ROSE 10 PERCENT TO $165 MILLION.SEES FY 2018 ADJUSTED EARNINGS PER SHARE $1.75 TO $1.90.AFFIRMS FULL-YEAR ADJUSTED DILUTED EARNINGS PER SHARE GUIDANCE.SEES 2018 DILUTED EARNINGS PER SHARE $0.87 TO $1.27.FY2018 EARNINGS PER SHARE VIEW $0.65 -- THOMSON REUTERS I/B/E/S.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up